Brief: Adverum Biotechnologies - On June 3, Rupert D'souza Chief Financial Officer Advised Co That He Was Resigning Effective Immediately
06/06/2022 22:16
June 6 (Reuters) - Adverum Biotechnologies Inc ADVM.O :
* ADVERUM BIOTECHNOLOGIES INC - ON JUNE 3, RUPERT D'SOUZA
CHIEF
FINANCIAL OFFICER ADVISED CO THAT HE WAS RESIGNING EFFECTIVE
IMMEDIATELY
* ADVERUM BIOTECHNOLOGIES INC - UPON D'SOUZA CEASING TO BE
CFO,
JOHN RAKOW BECAME SENIOR VICE PRESIDENT, ACTING CFO
* ADVERUM BIOTECHNOLOGIES INC - RAKOW ALSO ASSUMED ROLE OF
PRINCIPAL FINANCIAL OFFICER OF ADVERUM
Further company coverage: ADVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)